{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:06:24Z","timestamp":1772780784064,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673055"],"award-info":[{"award-number":["81673055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402595"],"award-info":[{"award-number":["81402595"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10753-019-00982-7","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T10:09:29Z","timestamp":1556273369000},"page":"1215-1227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Shikonin Controls the Differentiation of CD4+CD25+ Regulatory T Cells by Inhibiting AKT\/mTOR Pathway"],"prefix":"10.1007","volume":"42","author":[{"given":"Xiaolan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"key":"982_CR1","first-page":"170","volume":"26","author":"RK Gershon","year":"1975","unstructured":"Gershon, R.K. 1975. A disquisition on suppressor T cells. Transplantation Reviews 26: 170\u2013185.","journal-title":"Transplantation Reviews"},{"issue":"7","key":"982_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/08820139.2016.1193869","volume":"45","author":"M Azimi","year":"2016","unstructured":"Azimi, M., S. Aslani, S. Mortezaqholi, et al. 2016. Identification, isolation, and functional assay of regulatory T cells. Immunological Investigations 45 (7): 584\u2013602.","journal-title":"Immunological Investigations"},{"issue":"6","key":"982_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.it.2015.04.006","volume":"36","author":"X Li","year":"2015","unstructured":"Li, X., and Y. Zheng. 2015. Regulatory T cell identity: formation and maintenance. Trends in Immunology 36 (6): 344\u2013353.","journal-title":"Trends in Immunology"},{"issue":"1","key":"982_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1615\/CritRevImmunol.v32.i1.40","volume":"32","author":"WA Goodman","year":"2012","unstructured":"Goodman, W.A., K.D. Cooper, and T.S. McCormick. 2012. Regulation generation: the suppressive functions of human regulatory T cells. Critical Reviews in Immunology 32 (1): 65\u201379.","journal-title":"Critical Reviews in Immunology"},{"key":"982_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-0-12-387827-4.00002-4","volume":"112","author":"HM Lee","year":"2011","unstructured":"Lee, H.M., J.L. Bautista, and C.S. Hsieh. 2011. Thymic and peripheral differentiation of regulatory T cells. Advances in Immunology 112: 25\u201371.","journal-title":"Advances in Immunology"},{"issue":"1","key":"982_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/imr.12148","volume":"258","author":"A Huynh","year":"2014","unstructured":"Huynh, A., R. Zhang, and L.A. Turka. 2014. Signals and pathways controlling regulatory T cells. Immunological Reviews 258 (1): 117\u2013131.","journal-title":"Immunological Reviews"},{"issue":"2","key":"982_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ni.3077","volume":"16","author":"A Huynh","year":"2015","unstructured":"Huynh, A., M. DuPage, B. Priyadharshini, P.T. Sage, J. Quiros, C.M. Borges, N. Townamchai, V.A. Gerriets, J.C. Rathmell, A.H. Sharpe, J.A. Bluestone, and L.A. Turka. 2015. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nature Immunology 16 (2): 188\u2013196.","journal-title":"Nature Immunology"},{"issue":"2","key":"982_CR8","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar4545","volume":"16","author":"B Moradi","year":"2014","unstructured":"Moradi, B., P. Schnatzer, S. Hagmann, N. Rosshirt, T. Gotterbarm, J. Kretzer, M. Thomsen, H.M. Lorenz, F. Zeifang, and T. Tretter. 2014. CD4+CD25+\/highCD127low\/\u2212 regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints\u2014analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood. Arthritis Research & Therapy 16 (2): R97.","journal-title":"Arthritis Research & Therapy"},{"issue":"2","key":"982_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/eji.201344280","volume":"45","author":"K Ohl","year":"2015","unstructured":"Ohl, K., and K. Tenbrock. 2015. Regulatory T cells in systemic lupus erythematosus. European Journal of Immunology 45 (2): 344\u2013355.","journal-title":"European Journal of Immunology"},{"issue":"8","key":"982_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136485","volume":"10","author":"JD Lord","year":"2015","unstructured":"Lord, J.D., D.M. Shows, J. Chen, and R.C. Thirlby. 2015. Human blood and mucosal regulatory T cells express activation markers and inhibitory receptors in inflammatory bowel disease. PLoS One 10 (8): e0136485.","journal-title":"PLoS One"},{"issue":"1","key":"982_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","volume":"135","author":"L Zhang","year":"2010","unstructured":"Zhang, L., X.Q. Yang, J. Cheng, R.S. Hui, and T.W. Gao. 2010. Increased Th17 cells are accompanied by FoxP3(+)Treg cell accumulation and correlated with psoriasis disease severity. Clinical Immunology 135 (1): 108\u2013117.","journal-title":"Clinical Immunology"},{"issue":"2","key":"982_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000093849","volume":"213","author":"HJ Bovenschen","year":"2006","unstructured":"Bovenschen, H.J., I.M. van Vlijemen-willems, P.C. van de Kerkhof, and P.E. van Erp. 2006. Identification of lesional CD4+CD25+Foxp3+ regulatory T cells in psoriasis. Dermatology 213 (2): 111\u2013117.","journal-title":"Dermatology"},{"issue":"1","key":"982_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","volume":"174","author":"H Sugiyama","year":"2005","unstructured":"Sugiyama, H., R. Gyulai, E. Toichi, E. Garaczi, S. Shimada, S.R. Stevens, T.S. McCormick, and K.D. Cooper. 2005. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. Journal of Immunology 174 (1): 164\u2013173.","journal-title":"Journal of Immunology"},{"issue":"1","key":"982_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.det.2014.09.002","volume":"33","author":"J Kim","year":"2015","unstructured":"Kim, J., and J.G. Krueger. 2015. The immunopathogenesis of psoriasis. Dermatologic Clinics 33 (1): 13\u201323.","journal-title":"Dermatologic Clinics"},{"issue":"2","key":"982_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.intimp.2014.01.027","volume":"19","author":"Y Xu","year":"2014","unstructured":"Xu, Y., X. Xu, X. Gao, H. Chen, and L. Geng. 2014. Shikonin suppresses IL-17-induced VEGF expression via blockage of JAK2\/STAT3 pathway. International Immunopharmacology 19 (2): 327\u2013333.","journal-title":"International Immunopharmacology"},{"issue":"4","key":"982_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.intimp.2013.04.020","volume":"16","author":"D Liang","year":"2013","unstructured":"Liang, D., Y. Sun, Y. Shen, F. Li, X. Song, E. Zhou, F. Zhao, Z. Liu, Y. Fu, M. Guo, N. Zhang, Z. Yang, and Y. Cao. 2013. Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappa B signaling pathway. International Immunopharmacology 16 (4): 475\u2013480.","journal-title":"International Immunopharmacology"},{"key":"982_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12943-015-0435-9","volume":"14","author":"TJ Lin","year":"2015","unstructured":"Lin, T.J., H.T. Lin, W.T. Chang, P. Mitapalli. S, P.W. Hsiao, S.Y. Yin, and N.S. Yang. 2015. Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components. Molecular Cancer 14: 174.","journal-title":"Molecular Cancer"},{"issue":"11\u201312","key":"982_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.lfs.2011.07.002","volume":"89","author":"CC Lee","year":"2011","unstructured":"Lee, C.C., J.J. Kang, B.L. Chiang, C.N. Wang, and Y.W. Cheng. 2011. Shikonin inhibited mitogen-activated IL-4 and IL-5 production on EL-4 cells through downregulation of GATA-3 and c-Maf induction. Life Sciences 89 (11\u201312): 364\u2013370.","journal-title":"Life Sciences"},{"issue":"3","key":"982_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.20071477","volume":"205","author":"S Haxhinasto","year":"2008","unstructured":"Haxhinasto, S., D. Mathis, and C. Benoist. 2008. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. The Journal of Experimental Medicine 205 (3): 565\u2013574.","journal-title":"The Journal of Experimental Medicine"},{"issue":"22","key":"982_CR20","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S Sauer","year":"2008","unstructured":"Sauer, S., L. Bruno, A. Hertweck, D. Finlay, M. Leleu, M. Spivakov, Z.A. Knight, B.S. Cobb, D. Cantrell, E. O'Connor, K.M. Shokat, A.G. Fisher, and M. Merkenschlager. 2008. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proceedings of the National Academy of Sciences of the United States of America 105 (22): 7797\u20137802.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"982_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jdermsci.2017.01.001","volume":"86","author":"R Kubo","year":"2017","unstructured":"Kubo, R., S. Muramatsu, Y. Sagawa, C. Saito, S. Kasuya, A. Nishioka, E. Nishida, S. Yamazaki, and A. Morita. 2017. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis. Journal of Dermatological Science 86 (1): 46\u201353.","journal-title":"Journal of Dermatological Science"},{"issue":"2","key":"982_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jdermsci.2018.08.007","volume":"92","author":"CS Hau","year":"2018","unstructured":"Hau, C.S., T. Shimizu, Y. Tada, M. Kamata, S. Takeoka, S. Shibata, A. Mitsui, Y. Asano, M. Sugaya, T. Kadono, S. Sato, and S. Watanabe. 2018. The vitamin D3 analog, maxacalcitol, reduces psoriasiform skin inflammation by inducing regulatory T cells and downregulating IL-23 and IL-17 production. Journal of Dermatological Science 92 (2): 117\u2013126.","journal-title":"Journal of Dermatological Science"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-00982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-019-00982-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-00982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T23:20:02Z","timestamp":1587770402000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-019-00982-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s10753-019-00982-7","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,26]]},"assertion":[{"value":"26 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental procedures were approved and overseen by the Animal Care and Use Committee of the Shenyang Institute of Traditional Chinese Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}